Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/20/2025

Alternative Antibiotics for Syphilis in Patients Allergic to Both Penicillin and Doxycycline

Primary Alternative: Tetracycline

  • The Centers for Disease Control and Prevention recommends tetracycline 500 mg orally four times daily for 14 days as the established alternative when doxycycline cannot be used for early syphilis, with a treatment extension to 28 days for late latent syphilis or syphilis of unknown duration 1, 2, 3, 4, 5
  • Tetracycline treatment is associated with gastrointestinal side effects, which are more common than with doxycycline, potentially affecting compliance 1, 2

Secondary Alternatives When Compliance Can Be Ensured

Ceftriaxone

  • The Centers for Disease Control and Prevention supports ceftriaxone 1 gram daily (IM or IV) for 8-10 days as an alternative treatment, though clinical data remain limited 1, 2, 4, 5
  • Ceftriaxone requires a full 8-10 day course, as single-dose ceftriaxone is not effective 4, 5

Erythromycin

  • The Centers for Disease Control and Prevention notes erythromycin 500 mg orally four times daily for 14 days as less effective than other recommended regimens 4, 5
  • Erythromycin should only be considered when compliance with therapy and follow-up can be absolutely ensured 3, 4, 5

When Compliance Cannot Be Ensured

  • The Centers for Disease Control and Prevention strongly recommends penicillin desensitization when patient compliance with alternative therapy or follow-up cannot be guaranteed 1, 2, 3, 4, 5
  • Skin testing for penicillin allergy may help clarify true allergy status before proceeding with desensitization 1, 2, 4, 5

Critical Follow-Up Requirements

  • The Centers for Disease Control and Prevention requires close serologic monitoring for all patients on alternative therapies due to limited efficacy data 1, 2
  • HIV-infected patients require more frequent monitoring at 3-month intervals instead of 6-month intervals 1

Special Population Considerations

  • The Centers for Disease Control and Prevention mandates penicillin desensitization for pregnant patients, as no alternative antibiotics are recommended during pregnancy 1, 2, 3, 4, 5
  • The use of alternative therapies in HIV-infected patients must be undertaken with caution, as efficacy data in this population are lacking 1
  • For neurosyphilis, alternative regimens are not adequately studied, and penicillin desensitization is strongly preferred 1, 2

Alternative Treatments for Syphilis and Gonorrhea in Penicillin-Allergic Patients

Treatment Options

  • The Centers for Disease Control and Prevention recommends doxycycline 100 mg orally twice daily for 14 days as the preferred alternative treatment for early syphilis in penicillin-allergic patients 6
  • The Centers for Disease Control and Prevention suggests tetracycline 500 mg orally four times daily for 14 days as an effective alternative for early syphilis, but with more gastrointestinal side effects 6, 7
  • The Centers for Disease Control and Prevention recommends doxycycline 100 mg orally twice daily for 28 days for late latent syphilis or syphilis of unknown duration 8
  • The Centers for Disease Control and Prevention advises that penicillin desensitization should be considered for patients whose compliance with therapy or follow-up cannot be ensured 6, 7

Special Populations

  • The Centers for Disease Control and Prevention recommends that pregnant patients with penicillin allergy should be desensitized and treated with penicillin, as alternative treatments are not recommended during pregnancy 9, 10
  • The Centers for Disease Control and Prevention suggests that HIV-infected patients should be monitored more frequently, every 3 months instead of 6 months 9

Follow-up Recommendations

  • The Centers for Disease Control and Prevention recommends that quantitative nontreponemal serologic tests should be repeated at 6, 12, and 24 months 8
  • The Centers for Disease Control and Prevention advises that treatment failure should be suspected if nontreponemal test titers fail to decline fourfold within 6 months after therapy for primary or secondary syphilis 9